  | Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., Benzarti, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hermandez, D., Chakraborty, S., Ysebaert, L., François, J.-H., ... Moussay, E. (2023). Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood. doi:10.1182/blood.2022017839  Peer Reviewed verified by ORBi |
 | Isci, D., Veiga, D., Cokaiko, J., LOMBARD, A., Chevigné, A., ROGISTER, B., & Neirinckx, V. (10 April 2022). Study of the ACKR3/CXCR7 receptor in glioblastoma [Poster presentation]. Télévie Seminar, Liège, Belgium. |
 | D'Uonnolo, G., Reynders, N., Meyrath, M., Abboud, D., Uchański, T., Laeremans, T., Volkman, B. F., Janji, B., Hanson, J., Szpakowska, M., & Chevigné, A. (2022). The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B. Frontiers in Immunology, 13, 868579. doi:10.3389/fimmu.2022.868579 Peer Reviewed verified by ORBi |
 | Isci, D.* , D'Uonnolo, G.* , Wantz, M., Rogister, B., LOMBARD, A., Chevigné, A., Szpakowska, M., & Neirinckx, V. (28 December 2021). Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers, 14 (1), 130. doi:10.3390/cancers14010130 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Sanchez Gil, J., D'arrigo, P., Lebrun, M., Isci, D., Coppieters, N., Rogister, B., Chevigné, A., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted oncolytic herpesvirus [Poster presentation]. Journée des chercheurs Télévie. |
Sanchez Gil, J., Lebrun, M., Rogister, B., Chevigné, A., & Sadzot, C. (2020). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted oncolytic herpesvirus [Poster presentation]. Journée des chercheurs Télévie, Bruxelles, Belgium. |
Sanchez Gil, J., Lebrun, M., Rogister, B., Chevigné, A., & Sadzot, C. (2020). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted oncolytic herpesvirus [Poster presentation]. BELVIR. |
  | Baldo, A., Chevigné, A., Dumez, M.-E., Mathy, A., Power, P., Tabart, J., Cambier, L., Galleni, M., & Mignon, B. (2012). Inhibition of the keratinolytic subtilisin protease Sub3 from Microsporum canis by its propeptide (proSub3) and evaluation of the capacity of proSub3 to inhibit fungal adherence to feline epidermis. Veterinary Microbiology, 159 (3-4), 479-484. doi:10.1016/j.vetmic.2012.04.041 Peer Reviewed verified by ORBi |
Chevigné, A. (2008). Etude du mécanisme d’activation du zymogène de l’allergène Der p 1 de l’acarien Dermatophagoides pteronyssinus [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315367 |
 | Chevigné, A., Barumandzadeh, R., Groslambert, S., Cloes, B., Dehareng, D., Filée, P., Marx, J.-C., Frère, J.-M., Matagne, A., Jacquet, A., & Galleni, M. (16 November 2007). Relationship between propeptide pH unfolding and inhibitory ability during ProDer p 1 activation mechanism. Journal of Molecular Biology, 374 (1), 170-185. doi:10.1016/j.jmb.2007.08.025 Peer Reviewed verified by ORBi |
 | Chevigné, A., Yilmaz, N., Gaspard, G., Giannotta, F., François, J.-M., Frère, J.-M., Galleni, M., & Filée, P. (30 March 2007). Use of bifunctional hybrid beta-lactamases for epitope mapping and immunoassay development. Journal of Immunological Methods, 320 (1-2), 81-93. doi:10.1016/j.jim.2006.12.009 Peer Reviewed verified by ORBi |
 | Brans, A., Filée, P., Chevigné, A., Claessens, A., & Joris, B. (December 2004). New integrative method to generate Bacillus subtilis recombinant strains free of selection markers. Applied and Environmental Microbiology, 70 (12), 7241-7250. doi:10.1128/AEM.70.12.7241-7250.2004 Peer Reviewed verified by ORBi |